Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
about
HbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitusAssociation between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis.Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stageTCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortalityShifting the disease management paradigm from glucose: what are the pros?Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetesThe natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor deltaPathological aspects of lipid peroxidation.Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes.A systematic review of qualitative research on the contributory factors leading to medicine-related problems from the perspectives of adult patients with cardiovascular diseases and diabetes mellitus.Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.Cardiovascular Disease-Related Lifestyle Factors among People with Type 2 Diabetes in Pakistan: A Multicentre Study for the Prevalence, Clustering, and Associated Sociodemographic Determinants.Prevalence of dysglycemia among coronary artery bypass surgery patients with no previous diabetic history.Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretinsInsulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress.Silence of TRIB3 suppresses atherosclerosis and stabilizes plaques in diabetic ApoE-/-/LDL receptor-/- mice.Macrovascular complication phenotypes in type 2 diabetic patients.Vitamin D Receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach.Tribbles Homolog 3 Promotes Foam Cell Formation Associated with Decreased Proinflammatory Cytokine Production in Macrophages: Evidence for Reciprocal Regulation of Cholesterol Uptake and InflammationCardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms.Prevalence, types and factors associated with echocardiographic abnormalities among newly diagnosed diabetic patients at Mulago HospitalNicotinamide adenine dinucleotide phosphate oxidase and diabetes: vascular implications.In-vivo, non-invasive detection of hyperglycemic states in animal models using mm-wave spectroscopyImproving microvascular outcomes in patients with diabetes through management of hypertension.Macrovascular angiopathy in children and adolescents with type 1 diabetes.Evidence-based risk assessment and recommendations for physical activity clearance: diabetes mellitus and related comorbidities.Hydrogen sulfide and the metabolic syndrome.Association between genetics of diabetes, coronary artery disease, and macrovascular complications: exploring a common ground hypothesis.Metabolic hypertension: concept and practice.Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects.Serum C-reactive protein level and prediabetes in two Asian populations.Lipid profile and correlation to cardiac risk factors and cardiovascular function in type 1 adolescent diabetics from a developing country.Classification of skin phenotypes caused by diabetes mellitus using complex scattering parameters in the millimeter-wave frequency range.The Karlsburg Diabetes Management System: translation from research to eHealth application.The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances.Factors contributing to medicine-related problems in adult patients with diabetes and/or cardiovascular diseases in Saudi Arabia: a qualitative study.Effect of liraglutide on dietary lipid-induced insulin resistance in humans.Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography.Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease history or cardiovascular risk factors: results of a pooled analysis of phase 3 clinical trials.Genetic profiling of young and aged endothelial progenitor cells in hypoxia.
P2860
Q28728521-921E97E2-4752-4A8C-94FE-3CF2AF0DBE8DQ30251745-96D1B59C-2D9C-492A-A92D-7FB106FC8A0BQ30866303-7385A9D1-0103-482B-8325-3E1ACCDB7979Q30895121-27A61337-A5A7-4C04-8256-E6D8D3728237Q33610665-2AAA2B09-0A7A-4AD3-82A1-7003A7EB3456Q33699538-DD9C2773-31E7-4585-8765-6149500A2674Q33750688-92BAE3B9-D158-4691-AB38-7A54E7A757F4Q34137628-307B85D6-EB05-4764-84FF-8C0F77D7D47BQ34153553-C76B4DFC-96E2-409E-B27E-CF57E195CFAFQ34219865-A6148B67-B35A-49C5-BBB0-E3C2338C85C0Q34503739-43BB68A7-4491-4A45-BA5D-4452F9F42BDAQ35155082-FE97C6F5-6661-45EF-BF72-403D8B6A073DQ35227604-DA1D369B-896D-4143-B73D-38F7A4DF738DQ35249760-0DE5509F-AC88-4725-81B7-DC259B082812Q35565342-1FCED01F-D7BB-4EB2-9EA4-FD2C0089217EQ35696570-32082D0E-984B-4C63-B1FC-D3AAD17E7690Q36572131-DC6EAB5C-DCF3-4D82-9A6F-34D1F505E8F7Q36629490-D01B16B5-56B4-4A9C-8A52-E169A58CA7ECQ36825147-A7ADB9BE-4D87-4D08-BE75-048681A46A46Q37022802-6FFEA9DF-AF39-440E-9D4C-DD9429532CE1Q37025209-2E982CE2-67B0-480D-A6EC-D0AB410A7FE5Q37214226-F41C1926-F5F0-400E-90A7-04FE00C485EEQ37285455-B14AB1C4-AB4E-4F61-9BB5-59B43ED1354DQ37427251-C13720ED-92DB-4ABB-A2AD-E374BE59002EQ37857087-4010F918-0229-4758-B9C4-B8CA6EF0CA0FQ37908092-8A1A5C12-ACA9-405A-A038-515FE0A2B3CCQ37960613-7DF0D4ED-9EA9-463D-B5AC-ED79ECCD7896Q37970584-C2D46586-22AA-4969-8F78-D6974F3482E9Q38096977-6137B3D9-711D-4142-9558-830623E9C8B3Q38915869-ADD26EBC-4836-4C00-AFF0-DF9A327B0583Q39789739-B4B20279-F7C4-48C7-B02E-3D9EA2A38B22Q40008904-62D93AA4-F852-4591-A38B-8F3EA1E0D948Q41062586-B076490B-57EE-45A4-8A52-4A7C4BA971FDQ41961855-F116185F-8EE3-441C-AF9E-896B603E7617Q46962775-A09E1EC1-5657-49DB-BD3E-5D355EFFBF79Q47158839-7C1EBE12-BDAB-4354-8EEA-7ACBB103C437Q48292012-81148B15-6925-4461-AF84-B861B1FA0DD8Q51330918-6D15E5F6-D29A-4AF1-B496-52255F5309C5Q51339320-B45AD66F-DE88-46DA-B83D-C0A8A4E99E93Q55500589-805C7E80-3AB0-4B45-B41A-5323A4DA3ECE
P2860
Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Natural history of cardiovascu ...... abetes: role of hyperglycemia.
@en
Natural history of cardiovascu ...... abetes: role of hyperglycemia.
@nl
type
label
Natural history of cardiovascu ...... abetes: role of hyperglycemia.
@en
Natural history of cardiovascu ...... abetes: role of hyperglycemia.
@nl
prefLabel
Natural history of cardiovascu ...... abetes: role of hyperglycemia.
@en
Natural history of cardiovascu ...... abetes: role of hyperglycemia.
@nl
P2093
P921
P356
P1433
P1476
Natural history of cardiovascu ...... abetes: role of hyperglycemia.
@en
P2093
Barbara N Campaigne
Edvard Galic
Elwira Gromniak
Itamar Raz
Samiha Sarwat
Scott D Beattie
Zvonko Milicevic
P304
P356
10.2337/DC08-S240
P407
P478
31 Suppl 2
P577
2008-02-01T00:00:00Z